These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2766368)

  • 41. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
    Levavi H; Neri A; Bar J; Regev D; Nordenberg J; Ovadia J
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beta-hCG vs intact hCG assays in the detection of trophoblastic disease.
    Rinker AD; Tietz NW
    Clin Chem; 1989 Aug; 35(8):1799-800. PubMed ID: 2474392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical comparison of immunoradiometric assays for intact versus beta-specific human chorionic gonadotropin.
    Pardue MG; Taylor EH; London S; Walls RC; Pappas AA
    Am J Clin Pathol; 1990 Mar; 93(3):347-51. PubMed ID: 1689940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of a small immunoreactive HCG-like component isolated from urine of a patient with choriocarcinoma.
    Koyama K; Saito Y; Yamada Y; Tsuji Y; Isojima S
    Exp Clin Endocrinol; 1988 Dec; 92(2):199-210. PubMed ID: 3243339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Choriocarcinoma with markedly elevated serum hCG levels and negative urine hCG levels.
    Ajufo II; Lindow SW; Canty SH
    J Obstet Gynaecol; 2006 Jan; 26(1):83-5. PubMed ID: 16390729
    [No Abstract]   [Full Text] [Related]  

  • 46. Detection of trophoblastic tumour activity by pregnancy-specific beta-1-glycoprotein.
    Seppälä M; Rutanen EM; Heikinheimo M; Jalanko H; Engvall E
    Int J Cancer; 1978 Mar; 21(3):265-7. PubMed ID: 631928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Fragments of human chorionic gonadotropin (hCG): diagnosis of pregnancy and tumors].
    Lechner O; Dirnhofer S; Gerth R; Merz WE; Wick G; Berger P
    Wien Klin Wochenschr; 1995; 107(1):15-9. PubMed ID: 7871785
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Serum level of hCG-like substance in the patients of choriocarcinoma can be suppressed by Buserelin-administration].
    Kanazawa K; Aoki Y; Kurabayashi T; Yoshiya N; Honma S; Kodama S; Tanaka K
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1297-300. PubMed ID: 1431447
    [No Abstract]   [Full Text] [Related]  

  • 49. Some qualitative differences of hCG in serum from early and late pregnancies and trophoblastic diseases.
    Wide L; Hobson B
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):465-72. PubMed ID: 2827418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uterine choriocarcinoma with negative specific serum radioimmunoassay for human chorionic gonadotropins.
    Bakri Y; Lee JH; Jahshan AE; Lewis GC
    Gynecol Oncol; 1982 Aug; 14(1):112-8. PubMed ID: 7201439
    [No Abstract]   [Full Text] [Related]  

  • 51. Alpha-Subunit in sera of choriocarcinoma patients in remission.
    Quigley MM; Tyrey L; Hammond CB
    J Clin Endocrinol Metab; 1980 Jan; 50(1):98-102. PubMed ID: 6243136
    [No Abstract]   [Full Text] [Related]  

  • 52. Monoclonal versus polyclonal antibody radioimmunoassay against the beta-subunit of human chorionic gonadotropin in patients with gestational trophoblastic neoplasia.
    Wu T; Ballon SC; Teng NN
    Am J Obstet Gynecol; 1983 Dec; 147(7):821-5. PubMed ID: 6196974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epitope-selective, monoclonal-antibody-based immunoradiometric assays of predictable specificity for differential measurement of choriogonadotropin and its subunits.
    Schwarz S; Berger P; Wick G
    Clin Chem; 1985 Aug; 31(8):1322-8. PubMed ID: 2410164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum progesterone and serum human chorionic gonadotropin in gestational and nongestational choriocarcinoma.
    Dawood MY
    Am J Obstet Gynecol; 1975 Dec; 123(7):762-5. PubMed ID: 1200070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of nicked human chorionic gonadotropin content in clinical specimens by a specific immunometric assay.
    Kovalevskaya G; Birken S; Kakuma T; Schlatterer J; O'Connor JF
    Clin Chem; 1999 Jan; 45(1):68-77. PubMed ID: 9895340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Basic and clinical study of hCG--beta measured by hCG-beta test kit (author's transl)].
    Yanaihara T; Kanazawa M; Saito Y; Fukushima E; Kondo H
    Horumon To Rinsho; 1981 Jan; 29(1):105-8. PubMed ID: 6266705
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum HCG beta-core fragment is masked by associated macromolecules.
    Kardana A; Cole LA
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1393-5. PubMed ID: 1699964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinico-pathological study of choriocarcinoma localized in the lung with emphasis on hCG monitoring systems].
    Obata N; Sato Y; Sasaki A; Sudo Y; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):380-6. PubMed ID: 3549933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Fundamental evaluation of ELSA.F-beta HCG kit as an immunoradiometric assay specific for serum beta HCG].
    Omori S; Suehiro M; Fukuchi M
    Kaku Igaku; 1992 Jun; 29(6):709-16. PubMed ID: 1379310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. alpha-Fetoprotein, carcinoembryonic antigen, human chorionic gonadotropin and its beta subunit in metastatic choriocarcinoma: short-term follow-up and determinations of resistance during chemotherapy.
    Gips H; Vahrson H; Bailer P; Korte K
    Oncology; 1980; 37(3):157-62. PubMed ID: 6153786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.